Topical Application of Imiquimod as a Treatment for Chromoblastomycosis

Maria Da Gloria Sousa, Walter Belda Junior, Ricardo Spina, Priscila Ramos Lota, Neusa Sakai Valente, Gordon D. Brown, Paulo Ricardo Criado, Gil Benard

Research output: Contribution to journalArticle

36 Citations (Scopus)
4 Downloads (Pure)

Abstract

Chromoblastomycosis is a subcutaneous mycosis that remains a therapeutic challenge with no standard treatment and high rates of relapse. Based on our recent discoveries in mouse models, we tested the efficacy of using topical applications of imiquimod to treat patients afflicted with this chronic fungal infection. We report here on the first four patients, who all displayed a marked improvement of their lesions, both with and without concurrent oral antifungal therapy.
Original languageEnglish
Pages (from-to)1734-1737
Number of pages4
JournalClinical Infectious Diseases
Volume58
Issue number12
Early online date14 Mar 2014
DOIs
Publication statusPublished - 15 Jun 2014

Fingerprint

imiquimod
Chromoblastomycosis
Mycoses
Therapeutics
Recurrence

Keywords

  • imiquimod
  • chromoblastomycosis
  • Fonsecaea pedrosoi
  • innate immunity
  • antifungal treatment

Cite this

Sousa, M. D. G., Belda Junior, W., Spina, R., Lota, P. R., Valente, N. S., Brown, G. D., ... Benard, G. (2014). Topical Application of Imiquimod as a Treatment for Chromoblastomycosis. Clinical Infectious Diseases, 58(12), 1734-1737. https://doi.org/10.1093/cid/ciu168

Topical Application of Imiquimod as a Treatment for Chromoblastomycosis. / Sousa, Maria Da Gloria; Belda Junior, Walter; Spina, Ricardo; Lota, Priscila Ramos; Valente, Neusa Sakai; Brown, Gordon D.; Criado, Paulo Ricardo; Benard, Gil .

In: Clinical Infectious Diseases, Vol. 58, No. 12, 15.06.2014, p. 1734-1737.

Research output: Contribution to journalArticle

Sousa, MDG, Belda Junior, W, Spina, R, Lota, PR, Valente, NS, Brown, GD, Criado, PR & Benard, G 2014, 'Topical Application of Imiquimod as a Treatment for Chromoblastomycosis', Clinical Infectious Diseases, vol. 58, no. 12, pp. 1734-1737. https://doi.org/10.1093/cid/ciu168
Sousa MDG, Belda Junior W, Spina R, Lota PR, Valente NS, Brown GD et al. Topical Application of Imiquimod as a Treatment for Chromoblastomycosis. Clinical Infectious Diseases. 2014 Jun 15;58(12):1734-1737. https://doi.org/10.1093/cid/ciu168
Sousa, Maria Da Gloria ; Belda Junior, Walter ; Spina, Ricardo ; Lota, Priscila Ramos ; Valente, Neusa Sakai ; Brown, Gordon D. ; Criado, Paulo Ricardo ; Benard, Gil . / Topical Application of Imiquimod as a Treatment for Chromoblastomycosis. In: Clinical Infectious Diseases. 2014 ; Vol. 58, No. 12. pp. 1734-1737.
@article{68ce113243d144ce9c17f05edfa91d50,
title = "Topical Application of Imiquimod as a Treatment for Chromoblastomycosis",
abstract = "Chromoblastomycosis is a subcutaneous mycosis that remains a therapeutic challenge with no standard treatment and high rates of relapse. Based on our recent discoveries in mouse models, we tested the efficacy of using topical applications of imiquimod to treat patients afflicted with this chronic fungal infection. We report here on the first four patients, who all displayed a marked improvement of their lesions, both with and without concurrent oral antifungal therapy.",
keywords = "imiquimod, chromoblastomycosis, Fonsecaea pedrosoi, innate immunity, antifungal treatment",
author = "Sousa, {Maria Da Gloria} and {Belda Junior}, Walter and Ricardo Spina and Lota, {Priscila Ramos} and Valente, {Neusa Sakai} and Brown, {Gordon D.} and Criado, {Paulo Ricardo} and Gil Benard",
year = "2014",
month = "6",
day = "15",
doi = "10.1093/cid/ciu168",
language = "English",
volume = "58",
pages = "1734--1737",
journal = "Clinical Infectious Diseases",
issn = "1058-4838",
publisher = "Oxford University Press",
number = "12",

}

TY - JOUR

T1 - Topical Application of Imiquimod as a Treatment for Chromoblastomycosis

AU - Sousa, Maria Da Gloria

AU - Belda Junior, Walter

AU - Spina, Ricardo

AU - Lota, Priscila Ramos

AU - Valente, Neusa Sakai

AU - Brown, Gordon D.

AU - Criado, Paulo Ricardo

AU - Benard, Gil

PY - 2014/6/15

Y1 - 2014/6/15

N2 - Chromoblastomycosis is a subcutaneous mycosis that remains a therapeutic challenge with no standard treatment and high rates of relapse. Based on our recent discoveries in mouse models, we tested the efficacy of using topical applications of imiquimod to treat patients afflicted with this chronic fungal infection. We report here on the first four patients, who all displayed a marked improvement of their lesions, both with and without concurrent oral antifungal therapy.

AB - Chromoblastomycosis is a subcutaneous mycosis that remains a therapeutic challenge with no standard treatment and high rates of relapse. Based on our recent discoveries in mouse models, we tested the efficacy of using topical applications of imiquimod to treat patients afflicted with this chronic fungal infection. We report here on the first four patients, who all displayed a marked improvement of their lesions, both with and without concurrent oral antifungal therapy.

KW - imiquimod

KW - chromoblastomycosis

KW - Fonsecaea pedrosoi

KW - innate immunity

KW - antifungal treatment

U2 - 10.1093/cid/ciu168

DO - 10.1093/cid/ciu168

M3 - Article

VL - 58

SP - 1734

EP - 1737

JO - Clinical Infectious Diseases

JF - Clinical Infectious Diseases

SN - 1058-4838

IS - 12

ER -